High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study.

Villafane G, Thiriez C, Audureau E, Straczek C, Kerschen P, Cormier-Dequaire F, Van Der Gucht A, Gurruchaga JM, Quéré-Carne M, Evangelista E, Paul M, Defer G, Damier P, Remy P, Itti E, Fénelon G

Open source

DOI: 10.1111/ene.13474
Published: 2018 Jan
Container: European journal of neurology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/ene.13474,
  title = {High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study.},
  author = {Villafane G and Thiriez C and Audureau E and Straczek C and Kerschen P and Cormier-Dequaire F and Van Der Gucht A and Gurruchaga JM and Quéré-Carne M and Evangelista E and Paul M and Defer G and Damier P and Remy P and Itti E and Fénelon G},
  year = {2018},
  journal = {European journal of neurology},
  doi = {10.1111/ene.13474},
  url = {https://doi.org/10.1111/ene.13474}
}

RIS

TY  - JOUR
TI  - High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study.
AU  - Villafane G
AU  - Thiriez C
AU  - Audureau E
AU  - Straczek C
AU  - Kerschen P
AU  - Cormier-Dequaire F
AU  - Van Der Gucht A
AU  - Gurruchaga JM
AU  - Quéré-Carne M
AU  - Evangelista E
AU  - Paul M
AU  - Defer G
AU  - Damier P
AU  - Remy P
AU  - Itti E
AU  - Fénelon G
PY  - 2018
JO  - European journal of neurology
DO  - 10.1111/ene.13474
UR  - https://doi.org/10.1111/ene.13474
ER  -

APA

G, V., C, T., E, A., C, S., P, K., F, C., A, V. D. G., JM, G., M, Q., E, E., M, P., G, D., P, D., P, R., E, I., & G, F. (2018). High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study.. European journal of neurology. https://doi.org/10.1111/ene.13474

Source records

pubmed · retrieved 2026-09-26T17:36:59.141Z
europe-pmc · retrieved 2026-09-26T17:36:59.150Z
hal · retrieved 2026-09-26T17:36:59.258Z